Reply to Comment on: Is this a 737 Max Moment for Brolucizumab?
Publication
, Journal Article
Rosenfeld, PJ; Browning, DJ
Published in: American journal of ophthalmology
March 2021
Published In
American journal of ophthalmology
DOI
EISSN
1879-1891
ISSN
0002-9394
Publication Date
March 2021
Volume
223
Start / End Page
446 / 447
Related Subject Headings
- Ophthalmology & Optometry
- Intravitreal Injections
- Humans
- Antibodies, Monoclonal, Humanized
- 3212 Ophthalmology and optometry
- 1117 Public Health and Health Services
- 1113 Opthalmology and Optometry
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rosenfeld, P. J., & Browning, D. J. (2021). Reply to Comment on: Is this a 737 Max Moment for Brolucizumab? American Journal of Ophthalmology, 223, 446–447. https://doi.org/10.1016/j.ajo.2020.06.034
Rosenfeld, Philip J., and David J. Browning. “Reply to Comment on: Is this a 737 Max Moment for Brolucizumab?” American Journal of Ophthalmology 223 (March 2021): 446–47. https://doi.org/10.1016/j.ajo.2020.06.034.
Rosenfeld PJ, Browning DJ. Reply to Comment on: Is this a 737 Max Moment for Brolucizumab? American journal of ophthalmology. 2021 Mar;223:446–7.
Rosenfeld, Philip J., and David J. Browning. “Reply to Comment on: Is this a 737 Max Moment for Brolucizumab?” American Journal of Ophthalmology, vol. 223, Mar. 2021, pp. 446–47. Epmc, doi:10.1016/j.ajo.2020.06.034.
Rosenfeld PJ, Browning DJ. Reply to Comment on: Is this a 737 Max Moment for Brolucizumab? American journal of ophthalmology. 2021 Mar;223:446–447.
Published In
American journal of ophthalmology
DOI
EISSN
1879-1891
ISSN
0002-9394
Publication Date
March 2021
Volume
223
Start / End Page
446 / 447
Related Subject Headings
- Ophthalmology & Optometry
- Intravitreal Injections
- Humans
- Antibodies, Monoclonal, Humanized
- 3212 Ophthalmology and optometry
- 1117 Public Health and Health Services
- 1113 Opthalmology and Optometry
- 1103 Clinical Sciences